Key result
This review discusses the diagnosis and management options, including medical, surgical, and transcatheter treatments, for mitral valve disease in the elderly.
Why the study?
The prevalence of calcific mitral stenosis and mitral regurgitation is increasing alongside an aging population and rising heart failure cases, presenting specific diagnostic and management challenges.
This review summarizes the diagnosis and management options for mitral valve disease, including medical, surgical, and transcatheter approaches, specifically tailored for elderly patients.
May guide individualized decisions in elderly mitral valve disease; leaves open the need for dedicated randomized trials.
Calcific mitral stenosis, commonly seen in the elderly in developed countries, occurs primarily due to mitral annular calcification, and its prevalence is increasing secondary to an aging population. Mitral regurgitation, commonly seen across all age groups, occurs primarily due to anatomical or functional impairment of one or more components of the mitral apparatus or the left ventricle that are necessary for normal valve function, and its prevalence is increasing secondary to an increasing number of patients with heart failure. The current review discusses the diagnosis of and treatment options (medical, surgical, and transcatheter) for mitral valve disease, including the associated challenges, specifically in the elderly.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2024) conducted a review in Mitral Valve Disease. This review discusses the diagnosis and management options, including medical, surgical, and transcatheter treatments, for mitral valve disease in the elderly.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: